Advair 250/50 Now the Only Treatment Approved to Both Reduce Exacerbations and Improve Lung Function RESEARCH TRIANGLE PARK, N.C., May 1 -- Late yesterday the U.S. Food and Drug Administration ...
Aurobindo Pharma's subsidiary, Lannett Company LLC, has launched a generic version of GSK's Advair Diskus (100/50, 250/50 mcg) in the US market.
Advair Diskus 250/50 is also indicated to reduce exacerbations in patients with a history of exacerbations. Advair Diskus 250/50 is the only approved strength for COPD because an efficacy advantage of ...
Advair Diskus 250/50 is also indicated to reduce exacerbations in patients with a history of exacerbations. Advair Diskus 250/50 is the only approved strength for COPD because an efficacy advantage of ...
RESEARCH TRIANGLE PARK, N.C., May 1 Lateyesterday the U.S. Food and Drug Administration approved Advair Diskus(R)250/50 (fluticasone propionate 250 mcg and salmeterol 50 mcg inhalationpowder) for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results